ONE-WAYOngoing theme · still written in the latest filings
Business impact of organizational restructuring and M&A at customer pharmaceutical companies
A risk that organizational restructuring or M&A at customer pharmaceutical companies may change their competitive environment and research and development policies, affecting the Company's business strategy and financial performance.
Companies4How many companies write about this.
Threads4One company can carry more than one thread here.